Cleared Traditional

K161081 - SeaSpine Shoreline ACS - Anterior Cervical Standalone System (FDA 510(k) Clearance)

Sep 2016
Decision
149d
Days
Class 2
Risk

K161081 is an FDA 510(k) clearance for the SeaSpine Shoreline ACS - Anterior Cervical Standalone System. This device is classified as a Intervertebral Fusion Device With Integrated Fixation, Cervical (Class II - Special Controls, product code OVE).

Submitted by SeaSpine Orthopedics Corporation (Carlsbad, US). The FDA issued a Cleared decision on September 14, 2016, 149 days after receiving the submission on April 18, 2016.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation..

Submission Details

510(k) Number K161081 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 2016
Decision Date September 14, 2016
Days to Decision 149 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code OVE — Intervertebral Fusion Device With Integrated Fixation, Cervical
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation.

Similar Devices — OVE Intervertebral Fusion Device With Integrated Fixation, Cervical

All 15
HEDRON™ Cervical Spacers (HEDRON C-MIS™ Spacer)
K253876 · Globus Medical, Inc. · Dec 2025
FIX-C PEEK ACIF SA System
K251431 · Jeil Medical Corporation · Jun 2025
CYLOX® ST
K243188 · Signus Medizintechnik GmbH · Feb 2025
Genesys Spine AIS-C II Cervical Interbody Fusion System
K242483 · Genesys Spine · Feb 2025
Genesys Spine 3DP AIS-C II Cervical Interbody System
K233594 · Genesys Spine · Dec 2023
Shoreline ACS Interbody System
K233414 · SeaSpine Orthopedics Corporation · Nov 2023